Autoimmune Chronic Hepatitis Exacerbated by Alpha-Interferon

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Annals of Internal Medicine

• Publication date

  1992-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-116-1-51PMID 1727095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

  1991cited by this paper
• Second generation (RIBA) test in diagnosis of chronic hepatitis C.

  1991cited by this paper
• Type 2 autoimmune hepatitis and hepatitis C virus infection.

  1990cited by this paper
• Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

  1990cited by this paper
• Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

  1990cited by this paper
• Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

  1989cited by this paper
• Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

  1989cited by this paper
• Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

  1989cited by this paper
• Treatment of chronic type B hepatitis with recombinant α‐interferon induces autoantibodies not specific for autoimmune chronic hepatitis

  1989cited by this paper
• Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis

  1987cited by this paper
• Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

  1983cited by this paper

• Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling Pathway

  2023cites this paper
• Unexplained Liver Damage, Cryptogenic Liver Cirrhosis, and Steatohepatitis May Be Caused by Latent Chronic Toxoplasmosis

  2019cites this paper
• Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals.

  2019cites this paper
• Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection

  2018cites this paper
• Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study.

  2018cites this paper
• Drugs and Toxins

  2018cites this paper
• Role of LncRNA-AF085935, IL-10 and IL-17 in Rheumatoid Arthritis Patients With Chronic Hepatitis C

  2017cites this paper
• Kaleidoscope of autoimmune diseases in HIV infection

  2016cites this paper
• Coste-efectividad de los inhibidores de la proteasa de primera generación en el tratamiento de hepatitis crónica C genotipo 1

  2016cites this paper
• A case of antibody negative interferon-induced autoimmune hepatitis

  2016cites this paper
• Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.

  2015cites this paper
• Interferon beta 1 a-induced severe autoimmune hepatitis in patients with multiple sclerosis : report of two cases and review of the literature

  2015cites this paper
• CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY

  2015cites this paper
• Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.

  2014cites this paper
• Miscellaneous Antiviral Agents (Interferons, Imiquimod, Pleconaril)

  2014influential citation
• Does low‐dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

  2014cites this paper
• Acute and Acute Severe (Fulminant) Autoimmune Hepatitis

  2013cites this paper
• Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity

  2013cites this paper
• Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection

  2013cites this paper
• Hepatotoxicity of antibiotics: a review and update for the clinician.

  2013cites this paper
• Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon.

  2012cites this paper
• A Practical Guide to the Use of Interferons in the Management of Hepatitis Virus Infections

  2012cites this paper
• Antimitochondrial antibody ‐M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C

  2012cites this paper
• 13 – Hepatic injury due to drugs, herbal compounds, chemicals and toxins

  2012cites this paper
• Hepatitis C patients treated with interferon-alpha/ribavirin therapy develop autoantibodies to distinct cytoplasmic rod/ring structures composed of CTP/GTP nucleotide biosynthetic enzymes

  2012cites this paper
• Cytoplasmic Rods and Rings Autoantibodies Developed during Pegylated Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C

  2012cites this paper
• Major Therapeutic Uses of Interferons

  2012cites this paper
• The Potential Role of Cytokines in the Treatment of Viral Infections

  2012cites this paper
• Autoimmune hepatitis : a clinical study

  2011cites this paper
• A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome.

  2010cites this paper
• Early administration of ultraviolet treatment is effective in pegylated interferon alpha‐induced severe acute exacerbation of psoriasis: a case report and short review of the literature

  2010cites this paper
• Antiviral Drugs (Other than Antiretrovirals)

  2010cites this paper
• Autoimmune hepatitis, 2 years after successful peg-interferon-alpha 2b plus ribavirin treatment in a patient with chronic hepatitis C

  2010cites this paper
• Temporary stenting of acute airway stenosis with endotracheal tube – an effective method

  2010cites this paper
• Les cytokines du système immunitaire et leurs antagonistes en thérapeutique

  2009cites this paper
• Granulomatous hepatitis, perihepatic lymphadenopathies, and autoantibody positivity: an unusual association in a child with hepatitis C

  2009cites this paper
• Peginterferon (PEG-IFN) plus ribavirin combination therapy, but neither interferon nor PGE-IFN alone, induced type 1 diabetes in a patient with chronic hepatitis C.

  2009cites this paper
• Elevated hepatic transaminases associated with the use of interferon alfacon-1 and ribavirin.

  2009cites this paper
• Autoantibodies in Hepatitis C Infection: What Do They Mean?

  2009cites this paper
• Hépatites auto-immunes: aspects physiopathologiques, cliniques, histologiques et thérapeutiques

  2008cites this paper
• Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C.

  2008cites this paper
• Changes of serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C.

  2008cites this paper
• infected patients who are serum HBeAg negative but serum

  2008cites this paper
• Autoimmune hepatitis versus viral hepatitis C.

  2008cites this paper
• Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.

  2007cites this paper
• Association hépatite auto-immune et hépatite virale C : cinq nouvelles observations

  2006cites this paper
• Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation

  2006cites this paper
• [Hepatitis C-autoimmune hepatitis overlap syndrome: five new cases].

  2006cites this paper
• Les formes atypiques d’hépatite autoimmune

  2006cites this paper
• THE FREQUENCY OF NON-ORGAN-SPECIFIC AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS C AND ITS RELATION WITH DISEASE SEVERITY AND RESPONSE TO THERAPY

  2006cites this paper
• The Prevalence, Clinical Features and Response to Antiviral Therapy of Patients with Chronic Hepatitis C who are Seropositive for Liver–Kidney Microsome Type 1 Antibodies

  2005cites this paper
• Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

  2005cites this paper
• Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis

  2005cites this paper
• Autoantibodies in autoimmune liver disease.

  2005cites this paper
• Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome.

  2004cites this paper
• Hepatitis C virus‐related extra‐hepatic disease — aetiopathogenesis and management

  2004cites this paper
• [Treatment of hepatitis C virus associated extrahepatic manifestations].

  2002cites this paper
• Traitement des manifestations extrahépatiques associées à l'injection par le virus de l'hépatite C

  2002cites this paper
• [Interferon-alpha and auto-immunity].

  2002cites this paper
• Autoimmune hepatitis and its variant syndromes

  2001cites this paper
• Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.

  2001cites this paper
• Fulminant liver failure during interferon beta treatment of multiple sclerosis

  2001cites this paper
• Results of steroid-based therapy for the hepatitis C–autoimmune hepatitis overlap syndrome

  2001cites this paper
• Hepatitis C: a review and update.

  2001cites this paper
• [Autoimmune hepatitis. Physiopathologic, clinical, histological, and therapeutic features].

  2001cites this paper
• Hepatitis C: A review and update☆☆☆★

  2001cites this paper
• Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti‐liver/kidney microsome autoantibody type 1

  2001cites this paper
• Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C.

  2001cites this paper
• Tolerability of Treatments for Viral Hepatitis

  2001cites this paper
• Interferon alpha et auto-immunité

  2000cites this paper
• Treatment of autoimmune and extra-hepatic manifestations of HCV infection.

  2000cites this paper
• Treatment of hepatitis C-associated glomerular disease.

  2000cites this paper
• II Therapy of chronic hepatitis C

  2000cites this paper
• Patients with chronic hepatitis C--who should not be treated?

  2000cites this paper
• Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

  2000cites this paper
• Pleural effusion during interferon treatment for chronic hepatitis C.

  2000cites this paper
• Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.

  1999cites this paper
• Triggering of acute alcoholic hepatitis by α-interferon therapy

  1999cites this paper
• Disappearance of serum HCV-RNA after short-term prednisolone therapy in a patient with chronic hepatitis C associated with autoimmune hepatitis-like serological manifestations

  1999cites this paper
• Viral genotypes as determinants of autoimmune expression in chronic hepatitis C.

  1999cites this paper
• Variant forms of autoimmune hepatitis

  1999cites this paper
• Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection.

  1999cites this paper
• Triggering of acute alcoholic hepatitis by alpha-interferon therapy.

  1999cites this paper
• [Hepatitis C virus infection and thyroid diseases].

  1999cites this paper
• Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

  1999cites this paper
• Infection par le virus de l'hépatite C et pathologies thyroïdiennes

  1999cites this paper
• Renal manifestations of hepatitis C infection.

  1999cites this paper
• Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

  1999cites this paper
• A prospective evaluation of dermatological side‐effects during alpha‐interferon therapy for chronic viral hepatitis

  1998cites this paper
• Therapy of Viral Hepatitis

  1998cites this paper
• Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.

  1998cites this paper
• Cytokine-Induced Autoimmune Disorders

  1997cites this paper
• The spectrum of extrahepatic manifestations in hepatitis C virus infection

  1997cites this paper
• Acute hepatitis induced by α-interferon, associated with viral clearance, in chronic hepatitis C

  1997cites this paper
• Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile

  1997cites this paper
• Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.

  1997cites this paper
• [Interferon therapy and autoimmunity].

  1997cites this paper
• Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.

  1997cites this paper
• Case Report: Chronic Hepatitis C and Autoimmunity (Good Response to Immunosuppressive Treatment)

  1997cites this paper
• Treatment of acute and chronic hepatitis C.

  1997cites this paper